Monsanto, Junie S.
HRN: 21-88-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/11/2022
09/17/2022
IVT
500mg
Q8
Intra-abdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes